- Home
- ATEN vs NBTX Comparison
ATEN vs NBTX Comparison
Compare ATEN & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATEN
- NBTX
- Stock Information
- Founded
- ATEN 2004
- NBTX 2003
- Country
- ATEN United States
- NBTX France
- Employees
- ATEN N/A
- NBTX N/A
- Industry
- ATEN EDP Services
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- ATEN Technology
- NBTX Health Care
- Exchange
- ATEN Nasdaq
- NBTX Nasdaq
- Market Cap
- ATEN 1.3B
- NBTX 1.3B
- IPO Year
- ATEN 2014
- NBTX 2020
- Fundamental
- Price
- ATEN $17.08
- NBTX $20.96
- Analyst Decision
- ATEN Strong Buy
- NBTX Strong Buy
- Analyst Count
- ATEN 4
- NBTX 1
- Target Price
- ATEN $21.50
- NBTX $8.00
- AVG Volume (30 Days)
- ATEN 751.2K
- NBTX 68.9K
- Earning Date
- ATEN 11-04-2025
- NBTX 09-30-2025
- Dividend Yield
- ATEN 1.41%
- NBTX N/A
- EPS Growth
- ATEN 4.68
- NBTX N/A
- EPS
- ATEN 0.69
- NBTX N/A
- Revenue
- ATEN $284,406,000.00
- NBTX $11,930,711.00
- Revenue This Year
- ATEN $10.53
- NBTX N/A
- Revenue Next Year
- ATEN $7.41
- NBTX $122.94
- P/E Ratio
- ATEN $24.68
- NBTX N/A
- Revenue Growth
- ATEN 10.27
- NBTX N/A
- 52 Week Low
- ATEN $13.81
- NBTX $2.76
- 52 Week High
- ATEN $21.90
- NBTX $30.35
- Technical
- Relative Strength Index (RSI)
- ATEN 47.11
- NBTX 52.29
- Support Level
- ATEN $16.63
- NBTX $20.32
- Resistance Level
- ATEN $17.49
- NBTX $22.39
- Average True Range (ATR)
- ATEN 0.45
- NBTX 1.21
- MACD
- ATEN -0.02
- NBTX 0.03
- Stochastic Oscillator
- ATEN 33.89
- NBTX 50.47
About ATEN A10 Networks Inc.
A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.